![](/img/cover-not-exists.png)
Lamivudine prophylaxis prevents hepatitis b reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non–hodgkin's B cell lymphoma
Viganò, M., Grossi, G., Borsotti, E., Cappelletti, M., Goldaniga, M., Farina, L., Rumi, M., Corradini, P., Baldini, L., Colombo, M., Lampertico, P.Volume:
47
Language:
english
Journal:
Digestive and Liver Disease
DOI:
10.1016/j.dld.2015.01.135
Date:
February, 2015
File:
PDF, 54 KB
english, 2015